These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27364506)

  • 1. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
    Panchal H; Pilewskie ML; Sheckter CC; Albornoz CR; Razdan SN; Disa JJ; Cordeiro PG; Mehrara BJ; Matros E
    J Surg Oncol; 2019 Jan; 119(1):79-87. PubMed ID: 30480805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: Systematic review of patient reported outcomes.
    Srethbhakdi A; Brennan ME; Hamid G; Flitcroft K
    Psychooncology; 2020 Jun; 29(6):960-973. PubMed ID: 32201988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients.
    Fancellu A; Sanna V; Cottu P; Feo CF; Scanu AM; Farina G; Bulla A; Spanu A; Paliogiannis P; Porcu A
    Breast; 2018 Jun; 39():1-7. PubMed ID: 29454174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer.
    Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR
    Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
    Chiba A; Hoskin TL; Hallberg EJ; Cogswell JA; Heins CN; Couch FJ; Boughey JC
    Ann Surg Oncol; 2016 Oct; 23(10):3232-8. PubMed ID: 27338744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
    Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
    Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgeons' Perspectives of Contralateral Prophylactic Mastectomy.
    Bellavance E; Peppercorn J; Kronsberg S; Greenup R; Keune J; Lynch J; Collyar D; Magder L; Tilburt J; Hlubocky F; Yao K
    Ann Surg Oncol; 2016 Sep; 23(9):2779-87. PubMed ID: 27169770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
    Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
    J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
    Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
    Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising Rates of Contralateral Prophylactic Mastectomy as a Treatment for Early-Stage Breast Cancer.
    Jerome-DʼEmilia B; Kushary D; Suplee PD
    Cancer Nurs; 2019; 42(1):12-19. PubMed ID: 29251681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
    Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
    Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
    Agarwal S; Pappas L; Matsen CB; Agarwal JP
    Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
    Boughey JC; Attai DJ; Chen SL; Cody HS; Dietz JR; Feldman SM; Greenberg CC; Kass RB; Landercasper J; Lemaine V; MacNeill F; Song DH; Staley AC; Wilke LG; Willey SC; Yao KA; Margenthaler JA
    Ann Surg Oncol; 2016 Oct; 23(10):3100-5. PubMed ID: 27469117
    [No Abstract]   [Full Text] [Related]  

  • 19. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.
    Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
    JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
    Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Demsky R; Mancuso T; Sun P; Narod SA
    Ann Surg Oncol; 2021 Sep; 28(9):4967-4973. PubMed ID: 33761021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.